uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Viral Strategies to Regulate Transcription and Pre-mRNA Splicing
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Biochemistry and Microbiology.
2001 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

A typical DNA virus encodes for a few key regulatory proteins that modify the host cell biosynthetic machinery to achieve a selective viral gene statement. One such example is illustrated by the adenovirus E4-ORF4 protein, which form an enzymatically active complex with the serine and threonine-specific protein phosphatase 2A (PP2A). Almost all biological machines in a cell are regulated through reversible phosphorylation, and the E4-ORF4-PP2A complex has been shown to regulate diverse processes such as transcription, RNA splicing and apoptosis.

The adenovirus E1A gene encodes for a potent transcriptional activator protein, which stimulates transcription from all early viral promoters. Here we show that the E4-ORF4-PP2A complex autoregulates its own statement by blocking E1A-induced activation of the E4 promoter. Furthermore, the inhibitory activity of E4-ORF4 was specific for E1A-CR3-dependent transactivation. The E4-ORF4-PP2A complex also blocked E1A-induced activation of the E2 promoter, by reducing the stability of E2F/DNA complexes formed on the E2 promoter. The inhibitory effect of E4-ORF4, on both promoters, was relieved by inhibiting PP2A activity with okadaic acid, suggesting that E4-ORF4 regulates transcription by controlling the phosphorylated status of transcription factors important for E2 and E4 promoter activity.

The polyoma virus small T antigen ( py-ST) also interacts with PP2A. Previous results from our laboratory have shown that E4-ORF4 activates adenovirus IIIa splicing by inducing PP2A dephosphorylation of the SR family of splicing factors. The results presented here demonstrate that py-ST also activates IIIa pre-mRNA splicing. However, py-ST modulation of PP2A activity did not correlate with its IIIa splicing enhancer activity. Interestingly, py-ST activated IIIa splicing through a genetic element previously shown to be functional only in the context of an adenovirus infection. Thus, different mammalian viruses may have evolved a common strategy to take control of the RNA splicing machinery in the infected cell.

During an adenovirus infection the adenovirus E1B-55K and E4-ORF6 proteins form a stable complex that has been implicated in the selective nuclear to cytoplasmic transport of viral mRNAs, late after infection. Here we show that E4-ORF6 functions as an RNA splicing factor, specifically stimulating IIIa pre-mRNA splicing, both in vitro and in transient transfection assays. Interestingly, E4-ORF6 and E4-ORF4 both enhances IIIa splicing through the same genetic element; the IIIa splicing repressor element (3RE). Moreover, the E1B-55K protein augmented the stimulatory effect of E4-ORF6 on IIIa splicing. Collectively, these results may suggest that the E1B-55K/E4-ORF6 complex regulates RNA export by a direct effect on the efficiency of viral pre-mRNA splicing.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis , 2001. , 53 p.
Series
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 0282-7476 ; 1003
Keyword [en]
Biochemistry, Adenovirus E1B-55kDa, E4-ORF4, E4-ORF6 proteins, L1 mRNA, Polyoma virus small T antigen, regulation, transcription, splicing, PP2A
Keyword [sv]
Biokemi
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Research subject
Medical Virology
Identifiers
URN: urn:nbn:se:uu:diva-604ISBN: 91-554-4952-2 (print)OAI: oai:DiVA.org:uu-604DiVA: diva2:167216
Public defence
2001-03-21, Lecture Hall C10-305, BMC, Uppsala, 13:15 (English)
Available from: 2001-02-28 Created: 2001-02-28 Last updated: 2009-08-26Bibliographically approved

Open Access in DiVA

No full text
Buy this publication >>

By organisation
Department of Medical Biochemistry and Microbiology
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar

isbn
urn-nbn

Altmetric score

isbn
urn-nbn
Total: 836 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf